Vectorite Biomedical Inc. (TPEX: 4170)
Health Care · Biotechnology · TW
NT$12.20
-2.79% today · -16.7% 1Y
Vectorite Biomedical Inc. (TPEX: 4170) operates in the Biotechnology industry within the Health Care sector. The company is valued at $16.46M and employs 43 people.
Over the last twelve months the share price has lost 16.7%, trading between 11.40 and 18.15.
Tweenvest scores Vectorite Biomedical Inc. across four factors: quality 62/100, value 50/100, growth 75/100. Its strongest factor is growth.
4170 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.46M
- Revenue (TTM)
- $1.72M
- P/E
- 4.54
- EPS
- 2.69
- Dividend yield
- —
- Beta (5Y)
- 0.49
- 52-week high
- NT$18.15
- 52-week low
- NT$11.40
- Avg volume (3M)
- —
- Shares outstanding
- 43.77M
- Employees
- 43
- Next earnings
- —
About Vectorite Biomedical Inc.
Vectorite Biomedical Inc., established in 1993 and based in New Taipei City, Taiwan, is a biotechnology firm dedicated to research and development activities globally, including a strong presence in its home country. The company's operations encompass the manufacturing of specialized cell preparation products, in addition to providing full-spectrum services for the collection, processing, and secure storage management of immune cells. These advanced cellular preparations are vital for applications in the medical fields of infectious diseases, inflammatory conditions, and various oncological and tumor-related illnesses.
- ISIN
- TW0004170006
- Founded
- 2004
- Listed since
- Apr 15, 2013
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| TaiwanJ Pharmaceuticals Co., Ltd.TPEX: 6549 | $17.01M | NT$6.89 | -2.13% |
| Urteste S.A.WSE: URT | $16.82M | zł42.80 | +0.23% |
| NeuroScientific Biopharmaceuticals LimitedASX: NSB | $16.54M | AU$0.06 | +5.17% |
| Daesung Microbiological Labs. Co., Ltd.KOSDAQ: A036480 | $16.50M | ₩5,790.00 | -3.50% |
| Shaperon Inc.KOSDAQ: A378800 | $16.44M | ₩2,370.00 | -11.57% |
| Bioray Biotech Co., LtdTPEX: 7561 | $16.41M | NT$18.00 | -3.23% |
| Biotechnology Assets, S.A.BME: BST | $16.39M | €0.20 | +6.85% |
| aTyr Pharma, Inc.NasdaqCM: ATYR | $16.19M | $0.17 | -2.88% |
Figures last refreshed Oct 18, 2026.